Bide Pharmatech Co. Ltd. Class ASSE: 688073

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Use of Surplus Raised Funds and Remaining Over-raised Funds to Permanently Supplement Working Capital

Sep 28, 2026 · Issued by Bide Pharmatech Co. Ltd. Class A via Shanghai Stock Exchange

SSE: 688073

Announcement on Use of Surplus Raised Funds and Remaining Over-raised Funds to Permanently Supplement Working Capital

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

View original source (Shanghai Stock Exchange)

Earlier from Bide Pharmatech Co. Ltd. Class A

"BIDE PHARMATECH CO., LTD."Announcement on Expiration of Shareholding Reduction Plan by Shareholder and Results of Shareholding ReductionSep 10
"BIDE PHARMATECH CO., LTD."Announcement on the Vesting Results for the First Vesting Period of the Initial Grant and Reserved Grant under the 2024 Restricted Share Incentive PlanSep 8
"BIDE PHARMATECH CO., LTD."Announcement on Provision for Asset Impairment for the First Half of 2026Aug 28
"BIDE PHARMATECH CO., LTD."Announcement on Shareholding Reduction Plan of ShareholderAug 25

All Bide Pharmatech Co. Ltd. Class A news releases